Our latest insights and Updated Regulatory Resources to support your business Decisions
Clinical trials (CT) are research that studies new tests and treatments and evaluates their effects on human health outcomes. This article will explain the SFDA
NDLP: Saudi Pharmaceutical Market is expected at $11.7 billion by 2030 (Views on Medical Devices Included)
The Saudi National Industrial Development and Logistics Program (NDLP) predicts that the size of the pharmaceutical market in the Kingdom will reach 44 billion Riyals
In this post we detail the SFDA fees for registration of drugs and medical devices, and other types of products. It should help budgeting for regulatory costs.
Details about the SFDA pharmacovigilance in Saudi Arabia and its requirements. When and how to hire a QPPV or contract with a pharmacovigilance Consultancy as per the SFDA pharmacovigilance guidelines GVP.
How EMA and FDA approvals help in getting SFDA approval in an accelerated assessment procedure. Learn more about what is called Abridged and verification registration.
An overview on the regulatory strategy development process for the Saudi market. The analysis methods, elements to consider, documentation, and the series of recommended stages.